Adenovirus receptors: implications for tropism, treatment and targeting

Area of Science:

• Virology
• Gene Therapy
• Cancer Therapy

Background:

• Adenoviruses (Ads) are widely used as viral vectors in gene and cancer therapy.
• Clinical applications are hindered by vector accumulation in liver cells and poor transduction of target tissues like tumors.

Purpose of the Study:

• To review host molecules mediating Ad liver tropism.
• To explore mechanisms of Ad cell binding.
• To discuss prospects for detargeting Ads from the liver and retargeting them to specific cells for therapeutic applications.

Main Methods:

• Literature review of host molecules involved in Ad tropism.
• Analysis of Ad-host cell binding mechanisms.
• Discussion of vector engineering strategies for retargeting.

Main Results:

• Host molecules, such as coagulation factor X, are identified as mediators of Ad liver tropism.
• Understanding Ad binding mechanisms is crucial for vector design.
• Strategies for liver detargeting and tumor retargeting are being developed.

Conclusions:

• Modifying Ad vectors to overcome liver accumulation and enhance target cell transduction is critical for effective gene and cancer therapy.
• Future research should focus on engineering Ads with improved tissue specificity and reduced off-target effects.